Semba J, Ratnaraj N, Patsalos P N
INSEG (Epilepsy Research Group), Department of Clinical Neurology, London, U.K.
J Chromatogr. 1991 Apr 19;565(1-2):357-62. doi: 10.1016/0378-4347(91)80396-t.
A high-performance liquid chromatographic technique is described for the determination of milacemide and its primary metabolite glycinamide in rat plasma and cerebrospinal fluid. Milacemide and glycinamide are derivatized with fluorescamine to form a chromophore and a fluorophore and subsequent analysis using ultraviolet and fluorescence detectors, respectively. The extraction procedures are simple with a limit of detection 2 and 0.5 micrograms/ml for milacemide in plasma and cerebrospinal fluid, respectively, and 0.5 micrograms/ml for glycinamide in plasma or cerebrospinal fluid. The within-batch coefficients of variation for both analytes were less than 3%. Since only a small amount of sample is required, these techniques are well suited for the study of milacemide pharmacokinetics in the rat.
描述了一种高效液相色谱技术,用于测定大鼠血浆和脑脊液中的米那西肽及其主要代谢产物甘氨酰胺。米那西肽和甘氨酰胺用荧光胺衍生化,分别形成发色团和荧光团,随后分别使用紫外和荧光检测器进行分析。提取程序简单,血浆和脑脊液中米那西肽的检测限分别为2微克/毫升和0.5微克/毫升,血浆或脑脊液中甘氨酰胺的检测限为0.5微克/毫升。两种分析物的批内变异系数均小于3%。由于只需要少量样品,这些技术非常适合研究大鼠体内米那西肽的药代动力学。